Citadel Advisors’s Evolv Technologies EVLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.17M Sell
193,600
-211,600
-52% -$1.24M ﹤0.01% 7300
2025
Q4
$2.9M Sell
405,200
-81,900
-17% -$582K ﹤0.01% 5232
2025
Q3
$3.68M Sell
487,100
-66,600
-12% -$486K ﹤0.01% 4923
2025
Q2
$3.46M Buy
553,700
+196,200
+55% +$908K ﹤0.01% 4731
2025
Q1
$1.12M Buy
357,500
+80,600
+29% +$283K ﹤0.01% 6722
2024
Q4
$1.09M Sell
276,900
-306,200
-53% -$1.07M ﹤0.01% 6823
2024
Q3
$2.36M Buy
583,100
+437,600
+301% +$1.53M ﹤0.01% 5220
2024
Q2
$371K Sell
145,500
-24,400
-14% -$80.8K ﹤0.01% 8680
2024
Q1
$756K Buy
169,900
+44,300
+35% +$191K ﹤0.01% 7507
2023
Q4
$593K Sell
125,600
-38,400
-23% -$164K ﹤0.01% 7719
2023
Q3
$797K Buy
164,000
+59,200
+56% +$365K ﹤0.01% 7041
2023
Q2
$629K Buy
104,800
+103,200
+6,450% +$488K ﹤0.01% 7435
2023
Q1
$4.99K Buy
1,600
+300
+23% +$857 ﹤0.01% 13907
2022
Q4
$3.37K Buy
+1,300
New +$3.83K ﹤0.01% 14223

Other funds holding EVLV

Citadel Advisors's EVLV Position: Q1 2026 in Review

Citadel Advisors increased its Evolv Technologies (EVLV) stake by 86% in Q1 2026, buying an estimated $4.13M and bringing the position to 1,522,823 shares worth $9.21M. The position accounts for ﹤0.01% of the portfolio, ranked #3369.

Citadel Advisors first reported a position in EVLV in Q3 2021 and has held it in 18 quarters since. The position peaked at $22.9M in Q3 2025. 260 funds tracked by Wall St. Rank hold EVLV as of Q1 2026.

  • Citadel Advisors held 1,522,823 shares of Evolv Technologies worth $9.21M as of Q1 2026.
  • Citadel Advisors bought 705,371 Evolv Technologies shares in Q1 2026, an estimated $4.13M.
  • Evolv Technologies made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #3369 holding.
  • Citadel Advisors first reported a position in Evolv Technologies in Q3 2021 and has held it in 18 quarters since.
  • Citadel Advisors's Evolv Technologies position peaked at $22.9M in Q3 2025.
  • 260 funds tracked by Wall St. Rank held Evolv Technologies as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.